Cargando…

Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given

Detalles Bibliográficos
Autor principal:	Malviya, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184982/ https://www.ncbi.nlm.nih.gov/pubmed/32534688 http://dx.doi.org/10.1016/j.ihj.2020.04.006

Ejemplares similares

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020)

Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
por: Li, Qiuyu, et al.
Publicado: (2021)

Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Linschoten, Marijke, et al.
Publicado: (2021)

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
por: Ibáñez, Sebastián, et al.
Publicado: (2020)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

COVID-19: should oral vaccination strategies be given more consideration?
por: Mehan, Aman, et al.
Publicado: (2020)

COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?
por: Javelot, Hervé, et al.
Publicado: (2020)

Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”
por: Lammers, A.J.J., et al.
Publicado: (2021)

Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings
por: Mvumbi, Dieudonné M.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
por: Gbinigie, Kome, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine
por: Verheijen, S., et al.
Publicado: (2021)

Should activated charcoal be given after tramadol overdose?
por: Khosrojerdi, Hamid, et al.
Publicado: (2013)

Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted
por: Barraud, Damien, et al.
Publicado: (2023)

The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro
por: Li, Xia, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Public interest should be given priority over economic calculation
por: Gupta, Harish, et al.
Publicado: (2022)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine/chloroquine and azithromycin in COVID-19 patients: prospective study of electrical parameters
por: Ammor, Othmane, et al.
Publicado: (2021)

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020)

COVID-19 and risk of arrhythmia?
por: Matos Bela, Margarida, et al.
Publicado: (2020)

Impact of COVID-19 on Advanced Cancer Patients’ Pain Care: Warning About Chloroquine and Hydroxychloroquine
por: Aminnejad, Reza, et al.
Publicado: (2021)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19
por: Uzelac, Ilija, et al.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
por: Zou, Li, et al.
Publicado: (2020)

Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
por: Ruamviboonsuk, Paisan, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
por: Lei, Zi-Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b3mi80h25nnmqtu84pc5vonjkg